How should we choose optimal salvage treatments following BCMA-directed CAR-T therapy in multiple myeloma? Check out our review article out today summarizing recent studies and our approach to therapy sequencing from our team at @ucsfcancer.bsky.social #MMsm #myeloma dx.doi.org/10.1080/1750...

We are thrilled that the brilliant and innovative @simone-minnie will be joining UCSF myeloma program. She and her lab (positions open! aprecruit.ucsf.edu/JPF05438) will tackle some of the most pressing ?s in MM - mechanisms of T cell redirection resistance & optimal sequencing.